Literature DB >> 4136722

Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies.

B M Reedman, G Klein, J H Pope, M K Walters, J Hilgers, S Singh, B Johansson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4136722     DOI： 10.1002/ijc.2910130604

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  22 in total

Review 1.  Herpesviruses.

Authors:  M C Timbury; E Edmond
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

2.  Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection.

Authors:  A L Powell; W King; E Kieff
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

3.  Characterization of Epstein-Barr virus antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with Epstein-Barr virus-associated nuclear antigen.

Authors:  G Lenoir; M C Berthelon; M C Favre; G de-Thé
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

4.  Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.

Authors:  A L Epstein; W Henle; G Henle; J F Hewetson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

5.  Epstein-Barr virus-specific RNA. I. Analysis of viral RNA in cellular extracts and in the polyribosomal fraction of permissive and nonpermissive lymphoblastoid cell lines.

Authors:  S D Hayward; E D Kieff
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

6.  Epstein-barr virus-specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive, and prooductive infections.

Authors:  T Orellana; E Kieff
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

7.  Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.

Authors:  R S Blumberg; E G Sandstrom; T J Paradis; D N Neumeyer; M G Sarngadharan; K L Hartshorn; R E Byington; M S Hirsch; R T Schooley
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

8.  Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome.

Authors:  L Rymo; G Klein; A Ricksten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Isolation of a herpesvirus-specific DNA polymerase from tissues of an American patient with Burkitt lymphoma.

Authors:  H S Allaudeen; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

Review 10.  Proof for EBV's sustaining role in Burkitt's lymphomas.

Authors:  David Vereide; Bill Sugden
Journal:  Semin Cancer Biol       Date:  2009-07-21       Impact factor: 15.707
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.